Ask AI
ProCE Banner Activity

Advances in Personalized TKI Therapy for CP-CML: Nursing Considerations to Enhance Patient Education, Tolerability, and Adherence

Slideset

Downloadable slides on the role of oncology nurses in caring for patients with chronic-phase chronic myeloid leukemia (CP-CML) receiving TKI therapy, with a focus on patient education and managing AEs.

Released: July 09, 2026

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC, dba Decera Clinical Education.

ProCE Banner

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

Target Audience

This activity has been designed to meet the educational needs of oncology nurses and other healthcare professionals who care for patients with CML. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Support shared decision-making by educating patients with CP-CML about the latest clinical evidence and regulatory approvals for TKIs that are most likely to meet their treatment goals

  • Identify patients with CP-CML at risk for suboptimal adherence/ persistence to their TKI therapy

  • Apply evidence-based strategies for supportive care and dose optimization to manage TKI-related adverse events in patients with
    CP-CML